The prognosis of breast cancer has radically changed in recent years and continues to improve due to the broad application of effective therapies. New targeting strategies including targeted delivery of cytotoxic drugs via receptor-targeting agents have been developed. We summarize recent publications and developments of novel antibody-drug conjugates (ADCs) used to control breast cancer.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8257388 | PMC |
http://dx.doi.org/10.1155/2021/9927433 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!